Looking for More in Influenza?

Inbox

x

Pulmonology Advisor <editor@email.empr.com> Unsubscribe

10:31 PM (49 minutes ago)

to me

If you are having trouble viewing this email, click here.

Influenza Investigational Respiratory Illness Prevention Therapy Did Not Meet Trial End Point High-Dose Influenza Quadrivalent Approved for Patients 65 Years and Older Facebook Launches Preventive Health Tool Clinical Charts Influenza Vaccine Comparisons (2019−2020 Season)